$150.75
Today
as of Jul 22, 16:49 ET
Last 30 days
Recent Press Releases & News
Strong Results Boosted Guardant Health (GH) in Q2
Will Expanded Coverage of Guardant’s Shield Test Reshape UnitedHealth Group’s (UNH) Preventive Care Narrative?
The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High
Overview
52-week range
$40
$134
100% of range
Avg surprise (last 3)
-6.1%
Avg reaction (last 2)
-2.3%
50% positive
Latest IV / EM
66%
EM ±15.2% · $150 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.85 | $-0.71 | -19.7% | -10.4% | +0.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.74 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $-0.79 | $-0.79 | 0.0% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.77 | $-0.78 | +1.3% | — | -4.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.88 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.84 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.94 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.73 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.67 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | AMC | -$0.74 | -$0.79 | +6.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $302M | — | $265M | $232M | $203M | — | $191M | $177M |
| Cost of revenue | $105M | — | $94M | $81M | $75M | — | $74M | $72M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-121M | — | $-99M | $-106M | $-111M | — | $-117M | $-101M |
| Net income | $-112M | — | $-93M | $-100M | $-95M | — | $-108M | $-103M |
| EPS (diluted) | $-0.85 | — | $-0.74 | $-0.80 | $-0.77 | — | $-0.88 | $-0.84 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $989M | $378M | $580M | $629M | $699M | $526M | $585M | $934M |
| Inventory | $84M | $86M | $90M | $84M | $77M | $71M | $72M | $67M |
| Total current assets | $1.37B | $1.47B | $829M | $883M | $927M | $1.06B | $1.23B | $1.29B |
| Total assets | $1.92B | $2.01B | $1.28B | $1.33B | $1.34B | $1.49B | $1.54B | $1.61B |
| Long-term debt | $1.50B | $1.50B | $1.11B | $1.12B | $1.12B | $1.14B | — | — |
| Total liabilities | $2.10B | $2.11B | $1.63B | $1.64B | $1.60B | $1.63B | $1.60B | $1.61B |
| Total equity | $-181M | $-99M | $-354M | $-305M | $-251M | $-140M | $-60M | $-2M |